Skip to main content

Table 1 Characteristics of patients with type 2 diabetes mellitus and controls

From: Adipose tissue-derived cytokines and their correlations with clinical characteristics in Vietnamese patients with type 2 diabetes mellitus

Characteristics

Type 2 diabetes mellitus

Without type 2 diabetes mellitus

P value (*)

Overweight T2DM (n = 50)

Non-overweight T2DM (n = 88)

P value

Overweight individuals (n = 29)

Non-overweight individuals (n = 100)

P value

Demographics

 Age (years)

58 [40–84]

59 [40–69]

NS

59 [35–80]

57 [37–70]

NS

NS

 Gender (M/F)

29/21

50/38

NS

13/16

30/70

NS

0.0001

 Smoking (yes/no)

5/45

14/74

NS

2/27

4/96

NS

0.011

 Alcohol usage (yes/no)

15/35

26/62

NS

6/23

6/94

0.027

< 0.0001

 Physical exercise (yes/no)

35/15

73/15

NS

16/13

82/18

0.006

NS

 Family history of T2DM (yes/no)

3/47

11/77

NS

2/27

1/99

NS

0.009

Anthropometrics

 WHR

0.94 [0.86–1.07]

0.92 [0.83–1.18]

< 0.0001

0.93 [0.82–1.1]

0.88 [0.72–1.3]

0.001

< 0.0001

 BMI

26.7 [25–36.3]

22.4 [17.7–24.9]

< 0.0001

26.2 [25.1–29.6]

22.3 [16–24.9]

< 0.0001

0.008

Biochemical and clinical characteristics

 GOT (AST) (U/l)

22 [10–60]

19 [10–65]

0.025

27 [19–46]

24 [4–105]

0.043

0.006

 GPT (ALT) (U/l)

28 [11–109]

19.5 [8–86]

0.001

29 [19–68]

21 [7–177]

0.001

NS

 Total bilirubin (µmol/l)

9.4 [4.3–21.2]

7.5 [3.4–21.6]

0.047

9.4 [4.4–18.7]

9.8 [2.7–30]

NS

0.001

 Blood urea (mmol/l)

5.2 [3.2–9]

5.4 [2.1–11.8]

NS

5.5 [3.6–8.7]

5.65 [2.7–9.2]

NS

NS

 Blood creatinine (µmol/l)

69.5 [38–123]

68 [38–121]

NS

67 [48–128]

64 [45–96]

NS

0.015

 Fasting glucose (mmol/l)

8.6 [7–28.9]

7.65 [7–21.6]

0.002

5.3 [4.3–5.6]

5.3 [4–5.6]

NA

< 0.0001

 Urine glucose (pos/neg)

10/40

12/76

NS

0/29

6/94

NA

0.0026

 Triglycerides (mmol/l)

2.5 [0.4–9.1]

1.8 [0.34–19.6]

0.014

1.97 [0.5–6.0]

1.43 [0.3–16.8]

NS

0.023

 Total cholesterol (mmol/l)

5.0 [2.9–9.2]

5.0 [3.8–8.5]

NS

4.6 [3.3–7.3]

5.2 [3.0–7.8]

0.012

NS

 HDL-C (mmol/l)

1.1 [0.6–1.85]

1.2 [0.7–4.6]

0.042

1.26 [0.9–2.1]

1.35 [0.7–2.7]

0.019

0.002

 LDL-C (mmol/l)

2.7 [0.8–4.1]

3.0 [1.0–4.5]

NS

2.7 [0.8–4.8]

3.0 [1.1–5.9]

0.037

NS

 Glycosylated hemoglobin (HbA1c) (%)

7 [5.4–14.4]

6.8 [5.2–10.9]

NS

5.9 [4–6.4]

5.6 [4.2–8.5]

0.004

< 0.0001

 Insulin (mIU/l)

8.96 [2.7–54.5]

6.5 [1.3–23.2]

0.002

7.8 [3.5–10.2]

6.4 [0.08–17.5]

NS

0.004

 HOMA-IR

3.6 [1.3–48.9]

2.3 [0.4–9.7]

< 0.0001

1.8 [0.8–2.5]

1.5 [0.01–4.2]

NS

< 0.0001

 QUICKI

0.8 [0.5–0.9]

0.86 [0.7–1.07]

< 0.0001

0.9 [0.8–1.4]

0.9 [0.7–1.6]

NS

<  0.0001

 HOMA-β

33.6 [3.5–279.2]

27.4 [4.6–111.5]

NS

89.9 [38.5–222.1]

74.1 [3.0–370.8]

NS

< 0.0001

  1. T2DM type 2 diabetes mellitus, BMI body mass index, WHR waist-to-hip ratio, GOT Glutamic-Oxaloacetic Transaminase (AST), GPT Glutamic-Pyruvic Transaminase (ALT), HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, HOMA-IR Homeostasis Model Assessment-Insulin Resistance, QUICKI Quantitative Insulin Sensitivity Check Index, HOMA-β homeostatic model assessment-β-cell function, NA not applicable
  2. Values given are medians and range
  3. (*) Comparison between patients with type 2 diabetes mellitus and control individuals. P values were calculated by Chi square, Fisher’s exact tests or multi-factor ANOVA, where appropriate